Introduction
Orbital and ocular adnexal diseases (OOAD) encompass a wide range of conditions affecting the optic nerve, extraocular muscles, and orbital bones. These diseases often lead to significant visual impairment or permanent blindness. Animal models are indispensable for investigating the pathophysiology of OOAD and for the preclinical testing of novel therapeutic interventions. However, traditional assessment methods in these models frequently rely on invasive, terminal procedures such as histopathology.
While histopathology remains a gold standard, it presents significant limitations. Primarily, it precludes longitudinal assessment within the same subject, as the animal must be euthanized for tissue collection. Furthermore, such invasive methods are increasingly at odds with the ethical "3R" principles—Replacement, Reduction, and Refinement—which guide modern animal research toward minimizing animal use and suffering.
The Role of Non-Invasive Imaging
Non-invasive imaging technologies, including Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), and Diffusion Tensor Imaging (DTI), offer a promising alternative. These modalities allow for the repeated, longitudinal monitoring of disease progression and treatment response in living animals. This not only improves the statistical power of studies by allowing each animal to serve as its own control but also directly supports the "Reduction" and "Refinement" aspects of the 3R framework.
Despite the availability of these technologies, there is currently a lack of systematic consensus regarding which imaging modalities are most effective for specific orbital diseases or how well preclinical imaging findings translate to human clinical outcomes.
Methodology
This systematic review, registered with INPLASY, follows a rigorous protocol to evaluate the current landscape of orbital imaging in animal research.
Search Strategy and Selection
The authors will conduct a comprehensive search across four major databases: PubMed, Web of Science, Embase, and the Cochrane Library. The search includes all relevant studies published up to May 2024. The review focuses on original in vivo animal studies involving models of orbital or ocular adnexal diseases (e.g., inflammatory, neoplastic, or genetic conditions) that utilize imaging.
PICO Framework
The review is structured around the PICO framework:
- Population: Animal models of orbital and ocular adnexal diseases.
- Intervention: Non-invasive imaging modalities (MRI, CT, DTI, PET, SPECT, etc.).
- Comparator: Histopathology or alternative imaging techniques.
- Outcome: Diagnostic accuracy, utility for longitudinal monitoring, and impact on animal welfare/reduction.
Quality Assessment and Synthesis
To ensure methodological rigor, the authors will utilize the SYRCLE Risk of Bias tool, specifically designed for preclinical animal studies. Given the expected heterogeneity in species, disease models, and imaging hardware, the review will employ a qualitative synthesis to summarize findings rather than a quantitative meta-analysis.
Expected Impact and Future Directions
The results of this systematic review are expected to provide a definitive map of imaging modalities optimized for specific disease categories. For instance, it may clarify the superiority of MRI for soft-tissue tumors like optic gliomas versus the utility of Micro-CT for orbital fractures.
By identifying current gaps in technology and reporting, this review aims to promote the adoption of standardized, non-invasive imaging protocols. Ultimately, establishing these methods as primary endpoints in ophthalmic research will create a more reliable translational bridge between preclinical discovery and human clinical application.
Summary updated